We have located links that may give you full text access.
Identification of proteomic markers in head and neck cancer using MALDI-MS Imaging, LC-MS/MS and Immunohistochemistry.
Proteomics. Clinical Applications 2018 November 10
PURPOSE: The heterogeneity of squamous cell carcinoma tissue greatly complicates diagnosis and individualized therapy. Therefore, characterizing the heterogeneity of tissue spatially and identifying appropriate biomarkers is crucial. MALDI imaging (MSI) is capable of analyzing spatially resolved tissue biopsies on a molecular level.
EXPERIMENTAL DESIGN: We used MALDI MSI on snap frozen and formalin-fixed and paraffin-embedded (FFPE) tissue samples from patients with head and neck cancer (HNC) to analyze m/z values localized in tumor and non-tumor regions. Peptide identification was performed using LC-MS/MS and immunohistochemistry (IHC).
RESULTS: In both FFPE and frozen tissue specimens, we found eight characteristic masses of the tumor's epithelial region. Using LC-MS/MS, the peaks were identified as vimentin, keratin type II, nucleolin, heat shock protein 90, prelamin-A/C, junction plakoglobin and PGAM1. Lastly, vimentin, nucleolin and PGAM1 were verified with IHC.
CONCLUSIONS AND CLINICAL RELEVANCE: The combination of MALDI MSI, LC-MS/MS and subsequent IHC furnishes a tool suitable for characterizing the molecular heterogeneity of tissue. It is also suited for use in identifying new representative biomarkers to enable a more individualized therapy. This article is protected by copyright. All rights reserved.
EXPERIMENTAL DESIGN: We used MALDI MSI on snap frozen and formalin-fixed and paraffin-embedded (FFPE) tissue samples from patients with head and neck cancer (HNC) to analyze m/z values localized in tumor and non-tumor regions. Peptide identification was performed using LC-MS/MS and immunohistochemistry (IHC).
RESULTS: In both FFPE and frozen tissue specimens, we found eight characteristic masses of the tumor's epithelial region. Using LC-MS/MS, the peaks were identified as vimentin, keratin type II, nucleolin, heat shock protein 90, prelamin-A/C, junction plakoglobin and PGAM1. Lastly, vimentin, nucleolin and PGAM1 were verified with IHC.
CONCLUSIONS AND CLINICAL RELEVANCE: The combination of MALDI MSI, LC-MS/MS and subsequent IHC furnishes a tool suitable for characterizing the molecular heterogeneity of tissue. It is also suited for use in identifying new representative biomarkers to enable a more individualized therapy. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app